M11.14 Familial chondrocalcinosis, hand

Name of the Condition

• Familial chondrocalcinosis, hand

Summary

Familial chondrocalcinosis, hand is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the hand’s joint tissues, leading to inflammation and potential joint damage. It is a subtype of calcium pyrophosphate deposition disease (CPPD) with a genetic basis, often presenting with recurrent joint pain, swelling, and stiffness in the hand. Diagnosis relies on clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, hand is caused by genetic mutations that predispose individuals to abnormal calcium pyrophosphate crystal formation in the hand’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Genetic predisposition (family history of CPPD or chondrocalcinosis).
• Advanced age (increased risk with aging, though familial cases may present earlier).
• Metabolic conditions affecting calcium or pyrophosphate levels (e.g., hemochromatosis, hyperparathyroidism).
• Hand trauma or surgery.
• Certain medications (e.g., diuretics) that may alter crystal formation.

Symptoms

• Joint pain, swelling, and stiffness in the hand, often affecting the fingers or wrist.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in affected hand joints.
• Possible joint deformity over time.

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history (including family history), and imaging studies (e.g., X-rays, ultrasound) to detect crystal deposition or joint changes. Joint fluid analysis may be performed to identify CPPD crystals under polarized light microscopy. Additional tests, such as genetic testing, may be considered to confirm a hereditary pattern.

Treatment Options

Treatment focuses on managing symptoms and preventing joint damage. Options include nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation, colchicine for acute flares, and corticosteroid injections for localized symptoms. Physical therapy may help maintain joint function. In severe cases, surgery (e.g., joint replacement) may be considered.

Prognosis and Follow-Up

Prognosis varies depending on the extent of joint involvement and response to treatment. Early diagnosis and management can help slow disease progression. Regular follow-up with a healthcare provider is recommended to monitor symptoms, adjust treatment, and address complications. Long-term joint damage may occur in some cases.

Complications

• Chronic joint pain and stiffness.
• Progressive joint degeneration or osteoarthritis.
• Reduced hand function or disability.
• Recurrent acute inflammatory episodes.

Lifestyle & Prevention

• Maintain a healthy weight to reduce joint stress.
• Protect the hands from injury or overuse.
• Follow a balanced diet to support joint health.
• Avoid smoking, which may worsen inflammation.
• Engage in gentle hand exercises to preserve mobility.

When to Seek Professional Help

Seek medical attention if you experience persistent hand pain, swelling, or stiffness, especially with a family history of chondrocalcinosis. Acute, severe symptoms (e.g., sudden intense pain, redness) require prompt evaluation to rule out infection or other conditions.

Tips for Medical Coders

Use this code for familial chondrocalcinosis specifically affecting the hand. Document the anatomical site (hand) and confirm the hereditary nature of the condition. Ensure clinical documentation supports the diagnosis, including details of joint involvement and family history, to justify code assignment.